Your browser doesn't support javascript.
loading
Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control study.
Valachis, Antonis; Garmo, Hans; Fredriksson, Irma; Sund, Malin; Lagerqvist, Bo; Holmberg, Lars.
Afiliação
  • Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Garmo H; Regional Cancer Center Uppsala-Orebro, Uppsala, Sweden.
  • Fredriksson I; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Sund M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Lagerqvist B; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
  • Holmberg L; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Breast J ; 26(5): 981-987, 2020 05.
Article em En | MEDLINE | ID: mdl-31989762

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Varfarina / Neoplasias da Mama Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Varfarina / Neoplasias da Mama Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article